Pharmavite Amends CholestOff Claims After FTC Joins Heart Health Hunt

An attorney for Pharmavite questions federal regulators' apparent pursuit of cholesterol-lowering products after the firm satisfies a Federal Trade Commission investigation by revising marketing language for its CholestOff dietary supplement